Literature DB >> 25961078

Development and Validation of the Alzheimer's Questionnaire (AQ).

Michael Malek-Ahmadi1, Marwan N Sabbagh1.   

Abstract

The Alzheimer's Questionnaire (AQ) was developed to be brief and accurate informant-based assessment for primary care and geriatric physicians to use in screening for cognitive impairment. To date, several studies have been carried out and published establishing the diagnostic accuracy and psychometric validity of the AQ. This paper will provide a review of the studies that have been carried out to establish the AQ as a valid and accurate informant-based assessment of cognitive function.

Entities:  

Keywords:  Alzheimer’s disease; cognitive decline; dementia assessment; informant-based assessment; mild cognitive impairment

Year:  2015        PMID: 25961078      PMCID: PMC4423544     

Source DB:  PubMed          Journal:  J Nat Sci        ISSN: 2377-2700


  16 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

Review 2.  The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review.

Authors:  Anthony F Jorm
Journal:  Int Psychogeriatr       Date:  2004-09       Impact factor: 3.878

3.  Recognition of dementia: discovering the silent epidemic.

Authors:  E B Larson
Journal:  J Am Geriatr Soc       Date:  1998-12       Impact factor: 5.562

4.  Validation and diagnostic accuracy of the Alzheimer's questionnaire.

Authors:  Michael Malek-Ahmadi; Kathryn Davis; Christine Belden; Brecken Laizure; Sandra Jacobson; Roy Yaari; Upinder Singh; Marwan N Sabbagh
Journal:  Age Ageing       Date:  2012-02-23       Impact factor: 10.668

5.  Association between clinical measures and florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia.

Authors:  Michael M Witte; Paula Trzepacz; Michael Case; Peng Yu; Helen Hochstetler; Mitchell Quinlivan; Karen Sundell; David Henley
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

Review 6.  Mild cognitive impairment: an overview.

Authors:  Ronald C Petersen; Selamawit Negash
Journal:  CNS Spectr       Date:  2008-01       Impact factor: 3.790

7.  Telephone screening for mild cognitive impairment in hispanics using the Alzheimer's questionnaire.

Authors:  Ricardo Salazar; Carlos E Velez; Donald R Royall
Journal:  Exp Aging Res       Date:  2014       Impact factor: 1.645

8.  Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE.

Authors:  Michael Malek-Ahmadi; Kathryn Davis; Christine M Belden; Marwan N Sabbagh
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

9.  Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment.

Authors:  Michael Malek-Ahmadi; Kathryn Davis; Christine M Belden; Sandra Jacobson; Marwan N Sabbagh
Journal:  BMC Geriatr       Date:  2012-02-03       Impact factor: 3.921

10.  Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire.

Authors:  Michael Malek-Ahmadi; Kewei Chen; Kathryn Davis; Christine M Belden; Jessica Powell; Sandra A Jacobson; Marwan N Sabbagh
Journal:  Alzheimers Res Ther       Date:  2015-01-08       Impact factor: 6.982

View more
  1 in total

1.  Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.

Authors:  Kat Toups; Ann Hathaway; Deborah Gordon; Henrianna Chung; Cyrus Raji; Alan Boyd; Benjamin D Hill; Sharon Hausman-Cohen; Mouna Attarha; Won Jong Chwa; Michael Jarrett; Dale E Bredesen
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.